Company profile: Graphene 3D Lab
1.1 - Company Overview
Company description
- Provider of graphene-enhanced technologies improving 3D printing, including Conductive Graphene Filament for 3D-printed circuitry and sensors; air purification systems with graphene-enhanced filters; G6 Epoxy electrically conductive adhesives; advanced graphene composites; and direct sales of graphene and 2D materials via the Graphene Supermarket for academic, corporate, and industrial clients.
Products and services
- Conductive Graphene Filament: Brings users the ability to 3D print circuitry and sensors for electronic applications using a conductive graphene filament, custom-engineered
- Conductive Adhesives (Epoxies): Delivers a range of G6 Epoxy® electrically conductive adhesives incorporating graphene to improve electrical conductivity, strength, and durability, industrial-grade
- Direct Sales of Graphene Materials: Sells a wide range of graphene and 2D materials through its e-commerce platform, Graphene Supermarket®, catering to academic, corporate, and industrial clients, multi-material
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Graphene 3D Lab
Cambridge Graphene
HQ: United Kingdom
Website
- Description: Provider of graphene and 2D materials technology for licensing to manufacturers, offering graphene inks for inkjet and screen printing for coatings, printed electronics, sensors and energy storage; custom ink formulations; graphene-enhanced composite development; supercapacitors and batteries; Graphinks printable inks/coatings with high electrical and thermal conductivity, fire retardation and UV protection; and hBN dielectric inks.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Cambridge Graphene company profile →
Nanomi
HQ: The Netherlands
Website
- Description: Provider of microsphere and nanoparticle manufacturing and long-acting release medicine development, leveraging proprietary Microsieve technology for uniform particle size and precise extended dosing, and Monosphere technology for biodegradable monodisperse particles that encapsulate active compounds for controlled, long-term release; develops products in-house and in collaboration.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Nanomi company profile →
Sirnaomics
HQ: United States
Website
- Description: Provider of RNA interference-based therapeutics and delivery platforms. Develops STP705, an siRNA targeting TGF-β1 and COX-2 for non-melanoma skin cancer, cholangiocarcinoma, and hypertrophic scars; RNAi prophylactics and therapeutics for severe acute respiratory infection caused by 2019-nCoV; and delivery technologies including a polypeptide nanoparticle platform for mRNA vaccines/therapeutics and a GalNAc platform for liver-targeted RNAi.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Sirnaomics company profile →
Blueberry Therapeutics
HQ: United Kingdom
Website
- Description: Provider of nanomedicine-enabled topical treatments for dermatological conditions, including antifungal sprays BB2603 for onychomycosis and BB1202 for tinea pedis that enhance drug penetration with lower doses, and BB1511 cream for atopic dermatitis to support skin barrier and reduce inflammation; also conducts clinical trials to test safety and efficacy.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Blueberry Therapeutics company profile →
Arcturus Therapeutics
HQ: United States
Website
- Description: Provider of clinical-stage mRNA medicines and vaccines, including ARCT-154, a self-amplifying mRNA COVID-19 vaccine approved for use in adults; investigational therapies ARCT-032 and LUNAR-CF for cystic fibrosis and LUNAR-OTC for ornithine transcarbamylase deficiency; and platforms STARR™ mRNA Technology and LUNAR® lipid-mediated delivery for nucleic acid drug delivery.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Arcturus Therapeutics company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Graphene 3D Lab
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Graphene 3D Lab
2.2 - Growth funds investing in similar companies to Graphene 3D Lab
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Graphene 3D Lab
4.2 - Public trading comparable groups for Graphene 3D Lab
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →